Last reviewed · How we verify
Merestinib on Bone Metastases in Subjects With Breast Cancer
This is an open label, pharmacodynamics, intrapatient dose escalation phase 1B study.
Details
| Lead sponsor | University of Utah |
|---|---|
| Phase | PHASE1 |
| Status | TERMINATED |
| Enrolment | 2 |
| Start date | Thu Jan 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Jun 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Bone Metastases
- Breast Cancer
Interventions
- Merestinib
Countries
United States